TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novimedica AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,141
|
2,119
|
1,382 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
1,437
|
1,267
|
475 |
EBITDA |
1,412
|
1,265
|
475 |
Total assets |
1,818
|
1,572
|
1,225 |
Current assets |
1,807
|
1,560
|
1,214 |
Current liabilities |
475
|
369
|
254 |
Equity capital |
1,321
|
1,181
|
949 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.7%
|
75.1%
|
77.5% |
Turnover per employee |
2,141
|
2,119
|
1,382 |
Profit as a percentage of turnover |
67.1%
|
59.8%
|
34.4% |
Return on assets (ROA) |
79.0%
|
80.6%
|
38.8% |
Current ratio |
380.4%
|
422.8%
|
478.0% |
Return on equity (ROE) |
108.8%
|
107.3%
|
50.1% |
Change turnover |
22
|
737
|
-499 |
Change turnover % |
1%
|
53%
|
-27% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.